Misochip

1 known investors

MISO Chip develops a patient-derived tumor-on-a-chip microfluidic platform for ex vivo testing of anticancer agents on human tumors with a preserved native tumor microenvironment. It provides fee-for-service custom drug studies to biotech and pharmaceutical companies and sells lab-on-chip devices to academic researchers in translational oncology.